K
Kerry Taylor
Researcher at Australian National University
Publications - 200
Citations - 16213
Kerry Taylor is an academic researcher from Australian National University. The author has contributed to research in topics: Ontology (information science) & Wireless sensor network. The author has an hindex of 42, co-authored 195 publications receiving 15143 citations. Previous affiliations of Kerry Taylor include University of Surrey & City University of New York.
Papers
More filters
Journal ArticleDOI
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia
Stephen G. O'Brien,François Guilhot,Richard A. Larson,Insa Gathmann,Michele Baccarani,Francisco Cervantes,Jan J. Cornelissen,Thomas Fischer,Andreas Hochhaus,Timothy P. Hughes,Klaus Lechner,Johan Lanng Nielsen,Philippe Rousselot,Josy Reiffers,Giuseppe Saglio,John D. Shepherd,Bengt Simonsson,Alois Gratwohl,John M. Goldman,Hagop M. Kantarjian,Kerry Taylor,Gregor Verhoef,Ann E. Bolton,Renaud Capdeville,Brian J. Druker +24 more
TL;DR: Imatinib was superior to interferon alfa plus low-dose cytarabine as first-line therapy in newly diagnosed chronic-phase CML and was better tolerated than combination therapy.
Journal ArticleDOI
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia
Brian J. Druker,François Guilhot,Stephen G. O'Brien,Insa Gathmann,Hagop M. Kantarjian,Norbert Gattermann,Michael W. Deininger,Richard T. Silver,John M. Goldman,Richard Stone,Francisco Cervantes,Andreas Hochhaus,Bayard L. Powell,Janice Gabrilove,Philippe Rousselot,Josy Reiffers,Jan J. Cornelissen,Timothy P. Hughes,Hermine Agis,Thea Kolsen Fischer,Gregor Verhoef,John D. Shepherd,Giuseppe Saglio,Alois Gratwohl,Johan Lanng Nielsen,Jerald P. Radich,Bengt Simonsson,Kerry Taylor,Michele Baccarani,Charlene So,Laurie Letvak,Richard A. Larson +31 more
TL;DR: After 5 years of follow-up, continuous treatment of chronic-phase CML with imatinib as initial therapy was found to induce durable responses in a high proportion of patients.
Journal ArticleDOI
Ontology paper: The SSN ontology of the W3C semantic sensor network incubator group
Michael Compton,Payam Barnaghi,Luis Bermudez,Raúl García-Castro,Oscar Corcho,Simon Cox,John Graybeal,Manfred Hauswirth,Cory Henson,Arthur Herzog,Vincent Huang,Krzysztof Janowicz,W. David Kelsey,Danh Le Phuoc,Laurent Lefort,Myriam Leggieri,Holger Neuhaus,Andriy Nikolov,Kevin R. Page,Alexandre Passant,Amit P. Sheth,Kerry Taylor +21 more
TL;DR: The SSN ontology is described, which can describe sensors in terms of capabilities, measurement processes, observations and deployments and the use of the ontology in recent research projects is described.
Journal ArticleDOI
Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis
Susan Branford,Zbigniew Rudzki,Sonya Walsh,Ian H. Parkinson,Andrew Grigg,Jeff Szer,Kerry Taylor,Richard Herrmann,John F. Seymour,Christopher Arthur,David Joske,Kevin R. Lynch,Timothy P. Hughes +12 more
TL;DR: The detection of kinase domain mutations using a direct sequencing technique was almost always associated with imatinib resistance, and patients with mutations in the P-loop had a particularly poor prognosis.
Journal ArticleDOI
High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance.
Susan Branford,Zbigniew Rudzki,Sonya Walsh,Andrew Grigg,Christopher Arthur,Kerry Taylor,Richard Herrmann,Kevin Lynch,Timothy P. Hughes +8 more
TL;DR: A high frequency of mutations clustered within the ATP-binding region of BCR/ABL in resistant patients is confirmed and may allow intervention before relapse by identifying emerging mutations with defined impacts on imatinib binding.